International Journal of Gynecological Cancer, 1048-891X

Journal

More filtering options
  1. 2019
  2. Robot-assisted approach to cervical cancer (RACC): An international multi-center, open-label randomized controlled trial

    Falconer, H., Palsdottir, K., Stalberg, K., Dahm-Kähler, P., Ottander, U., Lundin, E. S., Wijk, L., Kimmig, R., Jensen, P. T., Eriksson, A. G. Z., Mäenpää, J., Jan Persson & Salehi, S., 2019 Jul 1, In : International Journal of Gynecological Cancer. 29, 6, p. 1072-1076 5 p.

    Research output: Contribution to journalArticle

  3. GestaTIonal TrophoblAstic NeoplasIa Ultrasound assessMent: TITANIUM study

    Verri, D., Pasciuto, T., Epstein, E., Fruscio, R., Mascilini, F., Moro, F., Scambia, G., Lil Valentin & Testa, A. C., 2019, In : International Journal of Gynecological Cancer.

    Research output: Contribution to journalArticle

  4. 2013
  5. Panitumumab and Pegylated Liposomal Doxorubicin in Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-Type: The PaLiDo Study, a Phase II Nonrandomized Multicenter Study.

    Steffensen, K. D., Waldstrøm, M., Pallisgård, N., Lund, B., Bergfeldt, K., Wihl, J., Keldsen, N., Marth, C., Vergote, I. & Jakobsen, A., 2013, In : International Journal of Gynecological Cancer. 23, 1, p. 73-80

    Research output: Contribution to journalArticle

  6. 2011
  7. Central nervous system metastases from epithelial ovarian cancer: Prognostic factors and outcome

    Cormio, G., Loizzi, V., Maddalena Falagario, Calace, A., Colamaria, A., De Tommasi, A. & Selvaggi, L. E., 2011 Jun 1, In : International Journal of Gynecological Cancer. 21, 5, p. 816-821

    Research output: Contribution to journalArticle

  8. 2010
  9. Adjuvant chemotherapy in endometrial cancer.

    Thomas Högberg, 2010, In : International Journal of Gynecological Cancer. 20, 11 Suppl 2, p. S57-S59

    Research output: Contribution to journalArticle

  10. 2009
  11. Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.

    Henic, E., Casslén, V., Høyer-Hansen, G., Stefan Hansson & Casslén, B., 2009, In : International Journal of Gynecological Cancer. 19, 2, p. 214-222

    Research output: Contribution to journalArticle

  12. 2008
  13. Response to letter of Escobar et al.

    Bartuma, K., Malander, S. & Mef Nilbert, 2008, In : International Journal of Gynecological Cancer. 18, p. 1386-1386

    Research output: Contribution to journalArticle

  14. Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up

    Sorbe, B., Andersson, H., Boman, K., Rosenberg, P. & Kalling, M., 2008, In : International Journal of Gynecological Cancer. 18, 4, p. 803-808

    Research output: Contribution to journalArticle

  15. 2007
  16. 2006
  17. Expression of matrix metalloproteinase-2 and mutant p53 is increased in hydatidiform mole as compared with normal placenta

    Petignat, P., Laurini, R., Goffin, F., Bruchim, I. & Bischof, P., 2006, In : International Journal of Gynecological Cancer. 16, 4, p. 1679-1684

    Research output: Contribution to journalArticle

  18. 2004
  19. 2003
  20. First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin

    Kristensen, GB., Vergote, I., Stuart, G., Del Campo, JM., Kaern, J., Lopez, AB., Eisenhauer, E., Aavall-Lundquist, E., Ridderheim, M., Havsteen, H., Mirza, MR., Scheistroen, M. & Vrdoljak, E., 2003, In : International Journal of Gynecological Cancer. 13, p. 172-177

    Research output: Contribution to journalArticle

  21. 2002
  22. TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer

    Koul, A., Pär-Ola Bendahl, Åke Borg, Mårten Fernö, Lidebring, MF., Hogberg, T., Einarsson, EL., Ridderheim, M. & Willen, R., 2002, In : International Journal of Gynecological Cancer. 12, 4, p. 362-371

    Research output: Contribution to journalArticle

  23. 2000
  24. BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features

    Koul, A., Malander, S., N. Loman, Pejovic, T., Heim, S., Willen, R., Johannsson, O., H. Olsson, Ridderheim, M. & Å. Borg Å, 2000, In : International Journal of Gynecological Cancer. 10, 4, p. 289-295 7 p.

    Research output: Contribution to journalArticle

  25. 1992